Paper Mulberry is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Broussonetia Papyrifera Pollen.
Product ID | 49288-0636_13c9eea1-38b5-472b-b735-a814ca886718 |
NDC | 49288-0636 |
Product Type | Human Prescription Drug |
Proprietary Name | Paper Mulberry |
Generic Name | Paper Mulberry |
Dosage Form | Injection, Solution |
Route of Administration | INTRADERMAL; SUBCUTANEOUS |
Marketing Start Date | 1974-03-23 |
Marketing Category | BLA / BLA |
Application Number | BLA102223 |
Labeler Name | Antigen Laboratories, Inc. |
Substance Name | BROUSSONETIA PAPYRIFERA POLLEN |
Active Ingredient Strength | 0 g/mL |
Pharm Classes | Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 1974-03-23 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA102223 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1974-03-23 |
Inactivation Date | 2019-10-21 |
Marketing Category | BLA |
Application Number | BLA102223 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1974-03-23 |
Inactivation Date | 2019-10-21 |
Marketing Category | BLA |
Application Number | BLA102223 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1974-03-23 |
Inactivation Date | 2019-10-21 |
Marketing Category | BLA |
Application Number | BLA102223 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1974-03-23 |
Inactivation Date | 2019-10-21 |
Marketing Category | BLA |
Application Number | BLA102223 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1974-03-23 |
Inactivation Date | 2019-10-21 |
Ingredient | Strength |
---|---|
BROUSSONETIA PAPYRIFERA POLLEN | .05 g/mL |